细胞裂解和破坏市场份额、规模、趋势、行业分析报告，按应用（蛋白质分离、下游加工、细胞器分离、核酸分离）；通过技术；副产品；按最终用途；按地区划分；分段预测，2021—2028

报告摘要

2020年，全球细胞裂解和破坏市场价值为40.2亿美元，预计在预测期内复合年增长率为9.3%。为开发个性化药物而开展的研发活动越来越多，导致细胞溶解和分裂增长。此外，政府对创新的COVID-19疫苗的创新和资金投入归因于裂解和破坏系统市场的增长。

了解更多有关此报告的信息:索取样本页

此外，对有效的肿瘤组织分离设备的需求不断增加，推动了基于微流体的新产品的发展，进一步推动了全球细胞裂解和破坏市场的需求。广泛的COVID-19流行病已经积极影响细胞破碎系统市场，由于对关键医疗解决方案和诊断试剂盒的需求不断增加。

The increasing number of R&D activities to develop COVID-19 vaccines boosts the demand for the technologies implemented in the bio-processing, which also comprises cell lysis & disruption. As a result, organizations are changing their target to providing bioprocessing-related solutions in the lysis & disruption systems market. Therefore, the rapid development of healthcare facilities and therapeutics during this period is exhibiting an upsurge in the global lysis & disruption systems market demand.

Industry Dynamics

Growth Drivers
这些技术被用于始终如一、完全有效地有效释放化合物。此外，它还改善了潜在的发展；因此，它正在推动全世界的裂解与破坏系统行业的增长。此外，越来越多的仪器的采用也提供了高产量和可裂解细胞，清洁无故障，确保可扩展性以及最大限度地发挥活性化合物。polytron均质机和搅拌器等几种广泛使用的仪器有助于处理大量酵母样本，并从大量哺乳动物复合组织中提取蛋白质。

许多仪器公司正在开发各种各样的仪器，以在细胞裂解和破坏市场上执行细胞裂解程序。因此，所有这些好处导致了对细胞裂解过程中使用的仪器的需求，这反过来又加速了裂解和裂解系统在未来一段时间内的市场增长。各种政府组织通过筹集资金、投资和提供赠款等形式提供支持。

报告分段

The market is primarily segmented on the basis of technique, product, application, end-use and region.

By Technique	副产品	按申请	按最终用途	按地区
试剂基 洗涤剂 酶的 物理破坏 机械均质 超声波均质 Pressure Homogenization Temperature Treatments	Instruments High Pressure Homogenizers 超音速仪 French Press Microfluidizer 磨珠机 Others 试剂和消耗品 Enzymes 洗涤剂Solutions Ionic detergent 非离子洗涤剂 Zwitterionic detergent Kits & Reagents	蛋白质分离 Downstream Processing 细胞器分离 核酸分离	学术研究机构 医院和诊断实验室 Cell Banks Pharmaceuticals & Biotechnology Companies	北美（美国、加拿大） 欧洲（法国、德国、英国、意大利、西班牙、荷兰、奥地利） Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea) 拉丁美洲（巴西、墨西哥、阿根廷） 中东和非洲（沙特阿拉伯、阿联酋、以色列、南非）

了解更多有关此报告的信息:索取样本页

应用洞察力

The protein isolation segment is expected to hold the highest revenue share over the forecast period. The rising need for proficient and quick lysis techniques can extort the proteins with the least oxidation and protein breakdown.Moreover, innovations in the highly developed bioprocessing equipment and reagents propel the segment growth. Therefore, these benefits offered by protein isolation lead to the dominance of the segment in the cellular disruption systems market.下游加工段预计show the fastest growth rate in the upcoming years.

对抗生素、抗体、疫苗、激素和酶等工业生物技术产品日益增长的需求正在推动裂解和破坏系统市场。Moreover, the ongoing efforts to develop vaccines for preventing coronavirus spread are also acting as a catalyzing factor for the segment demand. Accordingly, these are some prominent factors that fuel the segment growth in the upcoming years.

Insight by End-Use

The Pharmaceuticals & biotechnology companies segment had the highest revenue share in the global lysis & disruption systems market in 2020. The growing presence of the leading volume of the biotechnology companies, which discover the bioprocess techniques and molecular biology by utilizing lysis protocols.The efficiency and safety presented by biopharmaceuticals products and the capability to handle clinical conditions that were not cured previously are propelling the cell lysis & disruption market growth.

As a result, Pharmaceuticals organizations are rapidly moving towards developing biopharmaceuticals products, which, in turn, leads to segment dominance.The cell banking segment is projected to show the highest CAGR in the foreseen years. The various protocols for tumorigenicity research and testing have attributed to the considerable adoption of cell disruption methods across the biospecimen banking services and facilities.

Furthermore, the medical clinical study carried out for drug development is driving the potential growth in the forecasting period. Thus, these factors lead to segment growth in the estimated year.

Geographic Overview

Geographically, North America is leading the lysis & disruption systems market with the highest revenue share in 2020. The government's growing focus on supporting cancer research, molecular biology research, and evolving precision medicines are the factors that lead to the dominance of the regional cellular disruption market.此外，增加医疗保健领域的研发活动，以发现新的药物模式和治疗罕见疾病或健康问题的药物，可能会刺betway体育亚洲版入口激整个北美的裂解和破坏系统市场需求。

预计亚太地区在预测年份将显示出显著的复合年增长率。分析与破坏系统市场的参与者数量不断增加，以及主要在日本和中国等国家快速接受技术创新，推动了分析与破坏系统市场的增长。此外，政府还主动开发市场。The rapid growth of the personalized therapeutics for cancer treatment further contributes to the development of the regional market. Therefore, these factors fosters the lysis & disruption systems market growth in Asia Pacific in the upcoming scenario.

Competitive Landscape

Major market players includeBecton Dickinson&Company（BD）、Bio-Rad Laboratories、BioVision，Inc.，Cell Signaling Technology Inc.，Claremont BioSolutions，LLC，Covaris，Danaher Corp.，Roche Molecular Systems，Inc.，Geno Technology Inc.，默克KGaA，Microfluidics International Corp.，Miltenyi Biotec，Norgen Biotek Corp.，NZYTech Lda，Parr Instrument Company，PromoCell GmbH，Qsonica LLC，STEMCELL Technologies Inc。，以及赛默飞世尔科技公司。

细胞裂解和破坏市场报告范围

报告属性	细节
2020年的市场规模价值	40.2亿美元
2028年收入预测	79.5亿美元
CAGR	9.3%从2021到2028
Base year	2020
Historical data	2.01.6 - 2019
预测期	2.02.1.- 2028
数量单位	收入十亿美元和复合增长率从2021到2028
Segments covered	By Technique, By Product, By Application, By End-Use, By Region
Regional scope	北美、欧洲、亚太、拉丁美洲、中东和非洲
Key Companies	Becton Dickinson&Company（BD）、Bio-Rad Laboratories、BioVision，Inc.，Cell Signaling Technology Inc.，Claremont BioSolutions，LLC，Covaris，Danaher Corp.，Roche Molecular Systems，Inc.，Geno Technology Inc.，默克KGaA，Microfluidics International Corp.，Miltenyi Biotec，Norgen Biotek Corp.，NZYTech Lda，Parr Instrument Company，PromoCell GmbH，Qsonica LLC，STEMCELL Technologies Inc。，以及赛默飞世尔科技公司。